As the Q4 2024 pharma earnings period rolls on through the first month of President Donald Trump’s second term, executives ...
We recently compiled a list of the 12 Best International Dividend Stocks To Buy Now. In this article, we are going to take a ...
Invesco International Diversified Fund offers investors broad-based exposure to non-US equities by combining four portfolios ...
The fund is balanced across sectors and industries, with a focus on long-term growth areas and companies with sustainable ...
Novartis, Eli Lilly and more put on their deal-making caps, Bristol Myers Squibb targets $2 billion in savings through 2027, sales continue to soar for Lilly and Novo Nordisk’s GLP-1s and Regeneron ...
Ambea AB reported robust financial results for the fourth quarter of 2024, with significant increases in net sales and earnings per share. The company's stock surged by 7.76% following the ...
ACD/Labs recently released their 2025 Structure Elucidation & Verification Report, discussing how informatics trends have ...
Lyft (NASDAQ: LYFT) fell 10% after its guidance disappointed investors. The company sees first quarter gross bookings growth ...
Copyright © 2006-2024 Exchange Rates UK. All rights reserved. The information and news on this website is not financial advice or a recommendation. All displayed ...
Copyright © 2006-2024 Exchange Rates UK. All rights reserved. The information and news on this website is not financial advice or a recommendation. All displayed ...
AstraZeneca Pharma India Ltd. key Products/Revenue Segments include Pharmaceuticals and Sale of services for the year ending 31-Mar-2024.For the quarter ended 30-09-2024, the company has reported a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback